glp 1 anesthesia guidelines 2025 Glucagon-Like Peptide-1 Receptor Agonists in Perioperative Care The 2023 ASA position on

Both are reasonable, clinician-led options, and the better fit comes down to how you want to pay and how much hands-on contact you want

Read how Prime works with clients to address the increasing demand for GLP-1s and the impact on the total cost of care

For patients with existing cardiovascular risk factors, this safety profile matters significantly

As more people begin taking GLP-1 receptor agonists and other incretin-based drugs for glycemic control and weight management, new side effects of these treatments (both good and bad) are emerging

GLP-1 receptors (GLP-1R) are distributed across various organs in the human body